Biophytis S.A. (BPTS)
Total Valuation
Biophytis has a market cap or net worth of $7.20 million. The enterprise value is $14.46 million.
| Market Cap | 7.20M |
| Enterprise Value | 14.46M |
Important Dates
The last earnings date was Tuesday, April 18, 2023, before market open.
| Earnings Date | Apr 18, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Biophytis has 9.74 million shares outstanding. The number of shares has increased by 195.94% in one year.
| Shares Outstanding | 9.74M |
| Shares Change (YoY) | +195.94% |
| Shares Change (QoQ) | +87.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | 0.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -80.80% |
| Return on Capital (ROIC) | -188.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$827,642 |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.60% in the last 52 weeks. The beta is 1.24, so Biophytis's price volatility has been higher than the market average.
| Beta (1Y) | 1.24 |
| 52-Week Price Change | -84.60% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 2.47 |
| Relative Strength Index (RSI) | 46.26 |
| Average Volume (30 Days) | 1,136,220 |
Short Selling Information
| Short Interest | 45,387 |
| Short Previous Month | 40,406 |
| Short % of Shares Out | 0.47% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.62M |
| Pretax Income | -21.50M |
| Net Income | -21.52M |
| EBITDA | -18.80M |
| EBIT | -19.45M |
| Earnings Per Share (EPS) | $860.74 |
Balance Sheet
The company has $6.82 million in cash and $14.08 million in debt, giving a net cash position of -$7.26 million or -$0.75 per share.
| Cash & Cash Equivalents | 6.82M |
| Total Debt | 14.08M |
| Net Cash | -7.26M |
| Net Cash Per Share | -$0.75 |
| Equity / Book Value | -3.65M |
| Book Value Per Share | -0.37 |
| Working Capital | -2.94M |
Cash Flow
In the last 12 months, operating cash flow was -$18.59 million and capital expenditures -$229,456, giving a free cash flow of -$18.82 million.
| Operating Cash Flow | -18.59M |
| Capital Expenditures | -229,456 |
| Free Cash Flow | -18.82M |
| FCF Per Share | -$5.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -298.70% |
| FCF Yield | -261.21% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -195.94% |
| Shareholder Yield | -195.94% |
Analyst Forecast
The average price target for Biophytis is $15.00, which is 1,927.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 1,927.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 30, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 30, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |